Opsoclonus-myoclonus-ataxia syndrome as a complication of pembrolizumab treatment in an adult patient (a case report and literature review)
Background. Opsoclonus-myoclonus-ataxia syndrome (OMAS) in adults is an extremely rare condition, often leading to rapidly deteriorated neurological performance. The majority of published cases are considered as being of post-infectious, paraneoplastic or idiopathic origin. However, there have been...
Saved in:
| Main Authors: | K. A. Rumiantseva, A. Yu. Polushin, N. Kh. Abduloeva, Ya. B. Skiba, V. M. Moiseenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2023-03-01
|
| Series: | Эпилепсия и пароксизмальные состояния |
| Subjects: | |
| Online Access: | https://www.epilepsia.su/jour/article/view/876 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Etiological Factors of Opsoclonus Myoclonus Ataxia Syndrome: A Single Center Experience with Eight Children
by: Veysel Gök, et al.
Published: (2022-12-01) -
Outcome of Opsoclonus-Myoclonus Syndrome
by: J Gordon Millichap
Published: (2011-09-01) -
Opsoclonus-Myoclonus Syndrome in Children: Modern Data
by: Irina F. Fedoseeva, et al.
Published: (2025-02-01) -
A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome
by: Adalet Altunsoy, et al.
Published: (2024-02-01) -
Opsoclonus-Myoclonus Outcome
by: J Gordon Millichap
Published: (1995-08-01)